Craig Allen Bollig

Craig Allen Bollig

Auto-generated profile, based on publicly available information

Craig Allen Bollig

Department of Otolaryngology–Head and Neck Surgery Rutgers Robert Wood Johnson Medical School New Brunswick New Jersey USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2019 in Head & Neck
Verified
Journal Article
Closed access
PDF file
CBCraig A. Bollig
Craig A. Bollig
DGDavid R. Gilley
David R. Gilley
JAJumah Ahmad
Jumah Ahmad
JJJeffrey B. Jorgensen
Jeffrey B. Jorgensen

11 February 2021 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
AWAmit Walia
Amit Walia
JMJoshua Mendoza
Joshua Mendoza
CBCraig A. Bollig
Craig A. Bollig
ECEthan J. Craig
Ethan J. Craig
RJRyan S. Jackson
Ryan S. Jackson
PPPatrik Pipkorn
Patrik Pipkorn

1 October 2022 in JAMA Otolaryngology–Head & Neck Surgery
Verified
Journal Article
Open access
PDF file
CBCraig Allen Bollig
Craig Allen Bollig
AWAmit Walia
Amit Walia
PPPatrik Pipkorn
Patrik Pipkorn
RJRyan Jackson
Ryan Jackson
SPSidharth V. Puram
Sidharth V. Puram
JJJeffrey Brian Jorgensen
Jeffrey Brian Jorgensen
For most major bony head and neck defects, osseous free flaps have become the optimal method of reconstruction for restoration of form and function.1,2 With modern techniques, the success rates exceed 90% to 95% at most tertiary care centers but may be slightly lower for osseous flaps vs soft tissue–only flaps.1-6 Currently, the fibula free flap (FFF), osteocutaneous radial forearm free flap (OCRFFF), and scapula free flap (SFF) are the primary free tissues used for osseous head and neck reconstruction.7,8 Although each of these options has its benefits and limitations, surgeons often have preferences that may affect flap choice when multiple flaps could be used to reconstruct a given defect. Perioperative outcomes and complications associated with osseous head and neck reconstruction are relatively well described in the literature but are generally limited to single-institution reviews devoted to a single donor site or a comparison between 2 flap types.1-17 The series that have included data on all 3 osseous flap types have generally been underpowered to evaluate potential differences in outcomes among these 3 donor sites.3,4,10,11 Further delineating the association between osseous free flap type and perioperative outcomes could be valuable to head and neck reconstructive surgeons and their patients.

23 October 2020 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
CBCraig A. Bollig
Craig A. Bollig
CNChristopher I. Newberry
Christopher I. Newberry
TGTabitha L. I. Galloway
Tabitha L. I. Galloway
RZRobert P. Zitsch
Robert P. Zitsch
EHElyse K. Hanly
Elyse K. Hanly
JJJeffrey B. Jorgensen
Jeffrey B. Jorgensen

1 April 2022 in Head & Neck
Verified
Journal Article
Open access
CBCraig A. Bollig
Craig A. Bollig
BMBrian Morris
Brian Morris
VSVanessa C. Stubbs
Vanessa C. Stubbs
Background: Surgery + adjuvant therapy was shown to have improved overall survival (OS) versus nonsurgical treatment in T1‐T2N1‐N2b human papillomavirus (HPV)‐negative oropharyngeal cancer (OPC). Our objective was to compare OS in transoral robotic surgery (TORS) with neck dissection versus nonsurgical treatment for T1‐T2N0 HPV‐negative OPC.Methods: Patients with T1‐T2N0 HPV‐negative OPC were identified in the National Cancer Database. OS was compared between groups: (1) TORS with neck dissection +/− adjuvant therapy, (2) primary radiotherapy (>60 Gy) +/− chemotherapy using Kaplan–Meier and multivariable Cox proportional hazards models.Results: There were 665 (78.4%) patients treated nonsurgically and 183 (21.6%) patients in the TORS group. Adjusting for age, comorbidity score, facility type, tumor subsite, and tumor stage, primary nonsurgical treatment was associated with worse OS (hazard ratio: 1.90, 95% CI: 1.34–2.69).Conclusion: For T1‐T2N0 HPV‐negative OPC, TORS with neck dissection may be associated with a survival benefit over nonsurgical treatment.

22 September 2020 in Otolaryngology–Head and Neck Surgery
Verified
Journal Article
Closed access
PDF file
CBCraig A. Bollig
Craig A. Bollig
BKBrian P. Kinealy
Brian P. Kinealy
DGDavid R. Gilley
David R. Gilley
ACAndrew D. Clark
Andrew D. Clark
TGTabitha L.I. Galloway
Tabitha L.I. Galloway
GBGregory B. Biedermann
Gregory B. Biedermann